GSK To Report Core Operating Profit By Segment In Future Quarters

GSK Reports Regulatory Submission For Umeclidinium Monotherapy In U.S.

GlaxoSmithKline Q1 Profit Declines, Backs Full Year Goals

GlaxoSmithKline Q1 Profit Slides - Quick Facts

GSK, Theravance Submits Regulatory Application For UMEC/VI In Japan

Trade GSK now with

6/26/2012 1:21 PM ET

GlaxoSmithKline Plc. (GSK: Quote,GSK.L) said it intends to report core operating profit by segment in future quarters, and, as indicated in the first-quarter of 2012 Results Announcement.

On 28 March 2012, the company issued historical quarterly restatements for 2011 that included reclassifications of turnover consistent with the way in which the turnover is reported internally together with reconciliations of total results to the Group's core earnings on a quarterly basis for 2011.

Click here to receive FREE breaking news email alerts for GlaxoSmithKline PLC and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

<<Previous 130 Articles Next>>

Editors Pick

HP Profit Falls Yet Tops Estimates

Hewlett-Packard Co. said Wednesday after the markets closed that its second quarter profit fell 32% from last year, hurt by lower revenue and weaker margins amid a slump in PC sales. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations, but its quarterly revenue fell short of analysts' forecast.

Worries About Fed Tapering Lead To Sell-Off On Wall Street - U.S. Commentary

Stocks showed a substantial downturn over the course of the trading day on Wednesday after seeing some strength in morning trading. Renewed worries about the Federal Reserve tapering its asset purchase program contributed to the sharp pullback by the markets. The major averages climbed off their worst levels going into the close but still ended the day firmly negative.

Fed Minutes Show Some Members Want To Scale Back QE3 This Summer

Some members of the Federal Reserve favor scaling back the central bank's $85 billion a month asset purchase program this summer as long as the economy continues to improve, according the the minutes of the Fed's April 30-May 1 meeting. "A number of participants expressed willingness to adjust the...